Skip to main content

Table 2 Demographic and baseline characteristics of patients receiving treatments that did/did not follow the guidelines

From: The effect of adherence to guidelines for initial antiretroviral therapy on 1-year outcomes: a French cohort study

  All population Followed "when-to-start" guidelines Followed "what-to-start" guidelines
Characteristic N = 1,365 Yes (n = 1,214) No (n = 151) P Yes (n = 1,215) No (n = 150) P
Male (%) 69.7 68.6 78.2 0.02 68.7 77.3 0.03
Median Age (years) 37.3 37.5 34.7 0.002 37.1 38.5 -
MSM (%) 41.4 39.0 60.9 <0.001 41.1 44.0 -
HBV/HCV coinfection (%) 13.1 13.3 11.3 - 13.2 12.7 -
CDC stage C (%) 22.6 25.4 0 <0.001 20.2 41.3 <0.001
Median CD4 (/mm3) 248 230 513 <0.001 256 182 <0.001
Median HIV-RNA (log cps/mL) 4.8 4.8 4.4 <0.001 4.7 4.9 <0.001
HIV-RNA >105 copies/mL (%) 40.5 41.4 14.3 <0.0001 37.3 48.2 <0.0001
  1. Abbreviations: MSM men who have sex with men, HBV hepatitis B virus, HCV hepatitis C virus, CDC Centers for Disease Control and Prevention, HIV human immunodeficiency virus.